ScholarIQanswers from OpenAlex & ORCID
Thomas Peyret
ResearcherPublications, citations & collaboration network
Thomas Peyret is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Thomas Peyret have?
ScholarIQindexed works
Thomas Peyret has 18 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Thomas Peyret have?
ScholarIQcitation count
Thomas Peyret has 247 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Thomas Peyret?
ScholarIQh-index
Thomas Peyret has an h-index of 7 in OpenAlex.
What is the i10-index of Thomas Peyret?
ScholarIQi10-index
Thomas Peyret has an i10-index of 6 in OpenAlex.
What is the ORCID of Thomas Peyret?
ScholarIQorcid
The ORCID for Thomas Peyret is on the source record.
What is the OpenAlex record for Thomas Peyret?
ScholarIQopenalex
The OpenAlex for Thomas Peyret is on the source record.
What are the most-cited papers on Thomas Peyret?
ScholarIQmost cited works
Population pharmacokinetics of bevacizumab in cancer patients with external validation
Kelong Han, Thomas Peyret, Mathilde Marchand, Angelica Quartino, Nathalie Gosselin, Sandhya Girish, David E. Allison, Jin Jin
Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage
JE Edwards, Carl LaCerte, Thomas Peyret, NH Gosselin, Jean‐Francois Marier, Hofmann Af, Д. А. Шапиро
Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation
Kelong Han, Thomas Peyret, Angelica Quartino, Nathalie Gosselin, Sridharan Gururangan, Michela Casanova, Johannes H. M. Merks, Maura Massimino, Jacques Grill, Najat C. Daw, Fariba Navid, Jin Jin, David E. Allison
Population pharmacokinetic and pharmacodynamic analyses from a 4‐month intradose escalation and its subsequent 12‐month dose titration studies for a human monoclonal anti‐FGF23 antibody (KRN23) in adults with X‐linked hypophosphatemia
Xiaoping Zhang, Thomas Peyret, Nathalie Gosselin, Jean‐Francois Marier, Erik A. Imel, Thomas O. Carpenter
An integrated QSPR–PBPK modelling approach for<i>in vitro–in vivo</i>extrapolation of pharmacokinetics in rats
E. Kamgang, Thomas Peyret, Kannan Krishnan